Short and Long Term Efficacy of Combined Cabergoline and Octreotide Treatment in Acromegalic Patients

NCT01014793 · clinicaltrials.gov ↗

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: cabergoline

Sponsor

Federal University of São Paulo